Structure and regulation of opioid receptors.

Significant advances have been made in understanding the structure, function, and regulation of opioid receptors and endogenous opioid peptides since their discovery approximately 25 years ago. This review summarizes recent studies aimed at identifying key amino acids that confer ligand selectivity to the opioid receptors and that are critical constituents of the ligand binding sites. A molecular model of the delta receptor based on the crystal structure of rhodopsin is presented. Agonist-induced down regulation of opioid receptors is discussed, highlighting recent evidence for the involvement of the ubiquitin/proteasome system in this process.

[1]  P. Cuatrecasas,et al.  Interactions of ligands with morphine and enkephalin receptors are differentially affected by guanine nucleotide. , 1981, Molecular pharmacology.

[2]  R. Howells,et al.  Studies on inhibition of mu and delta opioid receptor binding by dithiothreitol and N-ethylmaleimide. His223 is critical for mu opioid receptor binding and inactivation by N-ethylmaleimide. , 1996, The Journal of biological chemistry.

[3]  C. Strader,et al.  Conserved aspartic acid residues 79 and 113 of the beta-adrenergic receptor have different roles in receptor function. , 1988, The Journal of biological chemistry.

[4]  C Evans,et al.  The conserved aspartate residue in the third putative transmembrane domain of the delta-opioid receptor is not the anionic counterpart for cationic opiate binding but is a constituent of the receptor binding site. , 1996, Molecular pharmacology.

[5]  T. Reisine,et al.  Mutagenesis of a Single Amino Acid in the Rat μ‐Opioid Receptor Discriminates Ligand Binding , 1998, Journal of neurochemistry.

[6]  D. Lissin,et al.  mu-Opioid receptor internalization: opiate drugs have differential effects on a conserved endocytic mechanism in vitro and in the mammalian brain. , 1998, Molecular pharmacology.

[7]  J. Benovic,et al.  β-Arrestin acts as a clathrin adaptor in endocytosis of the β2-adrenergic receptor , 1996, Nature.

[8]  S. Snyder,et al.  Opiate Receptor: Demonstration in Nervous Tissue , 1973, Science.

[9]  K. Tanaka.  Proteasomes: structure and biology. , 1998, Journal of biochemistry.

[10]  H. Mori,et al.  Stepwise Movement of Preproteins in the Process of Translocation across the Cytoplasmic Membrane of Escherichia coli(*) , 1995, The Journal of Biological Chemistry.

[11]  C. Chen,et al.  The third extracellular loop of the mu opioid receptor is important for agonist selectivity. , 1995, The Journal of biological chemistry.

[12]  E. J. Simon,et al.  Stereospecific binding of the potent narcotic analgesic (3H) Etorphine to rat-brain homogenate. , 1973, Proceedings of the National Academy of Sciences of the United States of America.

[13]  S. Snyder,et al.  Differential Regulation by Guanine Nucleotides of Opiate Agonist and Antagonist Receptor Interactions , 1980, Journal of neurochemistry.

[14]  D. Lissin,et al.  δ and κ Opioid Receptors Are Differentially Regulated by Dynamin-dependent Endocytosis When Activated by the Same Alkaloid Agonist* , 1997, The Journal of Biological Chemistry.

[15]  R. Howells,et al.  Studies on mu and delta opioid receptor selectivity utilizing chimeric and site-mutagenized receptors. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[16]  C. Strader,et al.  Allele-specific activation of genetically engineered receptors. , 1991, The Journal of biological chemistry.

[17]  G. Uhl,et al.  Human kappa opiate receptor second extracellular loop elevates dynorphin's affinity for human mu/kappa chimeras. , 1994, The Journal of biological chemistry.

[18]  C. Wahlestedt,et al.  Novel “Restoration of Function” Mutagenesis Strategy to Identify Amino Acids of the δ-Opioid Receptor Involved in Ligand Binding* , 1997, The Journal of Biological Chemistry.

[19]  P. van Kerkhof,et al.  Endocytosis and Degradation of the Growth Hormone Receptor Are Proteasome-dependent* , 2000, The Journal of Biological Chemistry.

[20]  A. S. Bogachuk,et al.  Two adjacent cysteine residues in the C‐terminal cytoplasmic fragment of bovine rhodopsin are palmitylated , 1988, FEBS letters.

[21]  Claes Wahlestedt,et al.  Involvement of Trp-284, Val-296, and Val-297 of the Human δ-Opioid Receptor in Binding of δ-Selective Ligands* , 1996, Journal of Biological Chemistry.

[22]  R. Robinson,et al.  CXII.—The morphine group. Part I. A discussion of the constitutional problem , 1923 .

[23]  P. Penela,et al.  Degradation of the G Protein-coupled Receptor Kinase 2 by the Proteasome Pathway* , 1998, The Journal of Biological Chemistry.

[24]  L. Terenius.  Stereospecific interaction between narcotic analgesics and a synaptic plasm a membrane fraction of rat cerebral cortex. , 2009, Acta pharmacologica et toxicologica.

[25]  John Hughes,et al.  Endogenous opioid peptides: multiple agonists and receptors , 1977, Nature.

[26]  R. Edwards,et al.  Cloning of a delta opioid receptor by functional expression. , 1992, Science.

[27]  L. Hicke.  Gettin' down with ubiquitin: turning off cell-surface receptors, transporters and channels. , 1999, Trends in cell biology.

[28]  M. Comb,et al.  A Mitogen-activated Protein Kinase Pathway Is Required for μ-Opioid Receptor Desensitization* , 1998, The Journal of Biological Chemistry.

[29]  D. Filliol,et al.  Constitutive Activation of the δ Opioid Receptor by Mutations in Transmembrane Domains III and VII* , 1999, The Journal of Biological Chemistry.

[30]  Yi-Jun Guo,et al.  Molecular basis for the interaction of histamine with the histamine H2 receptor. , 1992, The Journal of biological chemistry.

[31]  R. Lefkowitz,et al.  β-Arrestin1 Interacts with the Catalytic Domain of the Tyrosine Kinase c-SRC , 2000, The Journal of Biological Chemistry.

[32]  L. Devi,et al.  Dimerization of the delta opioid receptor: implication for a role in receptor internalization. , 1997, The Journal of biological chemistry.

[33]  Robert J. Lefkowitz,et al.  G Protein-coupled Receptors , 1998, The Journal of Biological Chemistry.

[34]  A. Ciechanover,et al.  The ubiquitin system. , 1998, Annual review of biochemistry.

[35]  Robert C. Thompson,et al.  A Chimeric Study of the Molecular Basis of Affinity and Selectivity of the κ and the δ Opioid Receptors. , 1995, The Journal of Biological Chemistry.

[36]  P. Breuer,et al.  Stabilization of Mutant 46-kDa Mannose 6-Phosphate Receptors by Proteasomal Inhibitor Lactacystin* , 1998, The Journal of Biological Chemistry.

[37]  L. Devi,et al.  Thr, Located within the COOH-terminal Tail of the Opiate Receptor, Is Involved in Receptor Down-regulation (*) , 1996, The Journal of Biological Chemistry.

[38]  H. Lester,et al.  The role of conserved aspartate and serine residues in ligand binding and in function of the 5‐HT1A receptor: A site‐directed mutation study , 1992, FEBS letters.

[39]  Robert C. Thompson,et al.  Mapping the receptor domains critical for the binding selectivity of δ-opioid receptor ligands , 1996 .

[40]  L. Hood,et al.  Porcine pituitary dynorphin: complete amino acid sequence of the biologically active heptadecapeptide. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[41]  H Hayashi,et al.  Site-directed mutagenesis of the histamine H1 receptor: roles of aspartic acid107, asparagine198 and threonine194. , 1994, Biochemical and biophysical research communications.

[42]  B. Carter,et al.  Go mediates the coupling of the mu opioid receptor to adenylyl cyclase in cloned neural cells and brain. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[43]  H. Loh,et al.  Mutation of a conserved serine in TM4 of opioid receptors confers full agonistic properties to classical antagonists. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[44]  Y. Chen,et al.  Molecular cloning of a rat kappa opioid receptor reveals sequence similarities to the mu and delta opioid receptors. , 1993, The Biochemical journal.

[45]  S. Ōmura,et al.  Degradation Process of Ligand-stimulated Platelet-derived Growth Factor β -Receptor Involves Ubiquitin-Proteasome Proteolytic Pathway * , 1995, Journal of Biological Chemistry.

[46]  Stanley J. Watson,et al.  Cloning and pharmacological characterization of a rat μ opioid receptor , 1993, Neuron.

[47]  A Goldstein,et al.  Cloning and pharmacological characterization of a rat kappa opioid receptor. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[48]  C. Fraser,et al.  Site-directed mutagenesis of alpha 2A-adrenergic receptors: identification of amino acids involved in ligand binding and receptor activation by agonists. , 1991, Molecular pharmacology.

[49]  T. Nakagawa,et al.  DAMGO, a μ‐opioid receptor selective agonist, distinguishes between μ‐ and δ‐opioid receptors around their first extracellular loops , 1995 .

[50]  G. Uhl,et al.  mu opiate receptor: cDNA cloning and expression. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[51]  Q. Deveraux,et al.  A 26 S protease subunit that binds ubiquitin conjugates. , 1994, The Journal of biological chemistry.

[52]  J. Whistler,et al.  Morphine-activated opioid receptors elude desensitization by β-arrestin , 1998 .

[53]  G. Schultz,et al.  μ and δ opioid receptors differentially couple to G protein subtypes in membranes of human neuroblastoma SH-SY5Y cells , 1993, Neuron.

[54]  G. Uhl,et al.  Human mu opiate receptor. cDNA and genomic clones, pharmacologic characterization and chromosomal assignment. , 1994, FEBS letters.

[55]  L. Devi,et al.  Sequestration of the delta opioid receptor. Role of the C terminus in agonist-mediated internalization. , 1996, The Journal of biological chemistry.

[56]  H. Loh,et al.  Molecular mechanisms and regulation of opioid receptor signaling. , 2000, Annual review of pharmacology and toxicology.

[57]  C. Zioudrou,et al.  Effect of δ-opioid antagonists on the functional coupling between opioid receptors and G-proteins in rat brain membranes , 1993 .

[58]  H. Kosterlitz,et al.  CHARACTERIZATION OF THE k‐SUBTYPE OF THE OPIATE RECEPTOR IN THE GUINEA‐PIG BRAIN , 1981 .

[59]  K. Palczewski,et al.  Crystal Structure of Rhodopsin: A G‐Protein‐Coupled Receptor , 2002, Chembiochem : a European journal of chemical biology.

[60]  J. Wess,et al.  Molecular basis of receptor/G-protein-coupling selectivity. , 1998, Pharmacology & therapeutics.

[61]  W. Schütz,et al.  Reverse intrinsic activity of antagonists on G protein-coupled receptors. , 1992, Trends in pharmacological sciences.

[62]  E. J. Simon,et al.  Opioid Receptor Multiplicity: Isolation, Purification, and Chemical Characterization of Binding Sites , 1993 .

[63]  S. Udenfriend,et al.  Characterization of rimorphin, a new [leu]enkephalin-containing peptide from bovine posterior pituitary glands. , 1982, Life sciences.

[64]  S. Udenfriend,et al.  Biochemistry of the enkephalins and enkephalin-containing peptides. , 1983, Archives of biochemistry and biophysics.

[65]  D Rodbard,et al.  Drug efficacy at guanine nucleotide-binding regulatory protein-linked receptors: thermodynamic interpretation of negative antagonism and of receptor activity in the absence of ligand. , 1992, Molecular pharmacology.

[66]  A. Goldstein,et al.  Expression cloning of cDNA encoding a seven-helix receptor from human placenta with affinity for opioid ligands. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[67]  G. Koski,et al.  Opiates inhibit adenylate cyclase by stimulating GTP hydrolysis. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[68]  H. Morris,et al.  Identification of two related pentapeptides from the brain with potent opiate agonist activity , 1975, Nature.

[69]  M. Obin,et al.  Ubiquitinylation and Ubiquitin-dependent Proteolysis in Vertebrate Photoreceptors (Rod Outer Segments) , 1996, The Journal of Biological Chemistry.

[70]  M. von Zastrow,et al.  Type-specific Sorting of G Protein-coupled Receptors after Endocytosis* , 2000, Journal of Biological Chemistry.

[71]  M. Abood,et al.  Molecular cloning and expression of a δ‐opioid recetpor from rat brain , 1994, Journal of neuroscience research.

[72]  M. Shahrestanifar,et al.  Sensitivity of μ and ∂ opioid receptor binding to N-ethylmaleimide , 1994, Regulatory Peptides.

[73]  R. Lefkowitz,et al.  Agonist-dependent phosphorylation of the mouse delta-opioid receptor: involvement of G protein-coupled receptor kinases but not protein kinase C. , 1995, Molecular pharmacology.

[74]  E. Kornilova,et al.  Lysosomal Targeting of Epidermal Growth Factor Receptors via a Kinase-dependent Pathway Is Mediated by the Receptor Carboxyl-terminal Residues 1022-1123* , 1996, The Journal of Biological Chemistry.

[75]  H. Akil,et al.  Key Residues Defining the μ‐Opioid Receptor Binding Pocket: A Site‐Directed Mutagenesis Study , 1997, Journal of neurochemistry.

[76]  H. Loh,et al.  Molecular characterization of opioid receptors. , 1990, Annual review of pharmacology and toxicology.

[77]  J. Venter,et al.  Site-directed mutagenesis of m1 muscarinic acetylcholine receptors: conserved aspartic acids play important roles in receptor function. , 1989, Molecular pharmacology.

[78]  P. Portoghese,et al.  A single residue, aspartic acid 95, in the delta opioid receptor specifies selective high affinity agonist binding. , 1993, The Journal of biological chemistry.

[79]  E. Hulme,et al.  C fragment of lipotropin has a high affinity for brain opiate receptors , 1976, Nature.

[80]  Brigitte L. Kieffer,et al.  Role of Aromatic Transmembrane Residues of the -Opioid Receptor in Ligand Recognition (*) , 1996, The Journal of Biological Chemistry.

[81]  M. Zastrow,et al.  Downregulation of G protein-coupled receptors , 2000, Current Opinion in Neurobiology.

[82]  K. Chaturvedi,et al.  μ Opioid receptor: role for the amino terminus as a determinant of ligand binding affinity , 2000 .

[83]  A Herz,et al.  Antagonists with negative intrinsic activity at delta opioid receptors coupled to GTP-binding proteins. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[84]  L. Hicke,et al.  A function for monoubiquitination in the internalization of a G protein-coupled receptor. , 1998, Molecular cell.

[85]  G. Dondio,et al.  Pharmacological profiles of selective non-peptidic δ opioid receptor ligands , 2000 .

[86]  A. Blume.  Opiate binding to membrane preparations of neuroblastoma x glioma hybrid cells NG108-15: effects of ions and nucleotides. , 1978, Life sciences.

[87]  M. Billeter,et al.  MOLMOL: a program for display and analysis of macromolecular structures. , 1996, Journal of molecular graphics.

[88]  Lei Yu,et al.  Molecular cloning and functional expression of a mu opioid receptor from rat brain , 1994, Regulatory Peptides.

[89]  M. Caron,et al.  Palmitoylation of the human beta 2-adrenergic receptor. Mutation of Cys341 in the carboxyl tail leads to an uncoupled nonpalmitoylated form of the receptor. , 1989, The Journal of biological chemistry.

[90]  G. Milligan,et al.  Agonist activation of p42 and p44 mitogen-activated protein kinases following expression of the mouse delta opioid receptor in Rat-1 fibroblasts: effects of receptor expression levels and comparisons with G-protein activation. , 1996, The Biochemical journal.

[91]  D. Grandy,et al.  Analysis of selective binding epitopes for the kappa-opioid receptor antagonist nor-binaltorphimine. , 1995, Molecular pharmacology.

[92]  G. Uhl,et al.  -mu opiate receptor. Charged transmembrane domain amino acids are critical for agonist recognition and intrinsic activity. , 1994, The Journal of biological chemistry.

[93]  S. Ōmura,et al.  Degradation of the Met tyrosine kinase receptor by the ubiquitin-proteasome pathway , 1997, Molecular and cellular biology.

[94]  M. Caron,et al.  Role of β-Arrestin in Mediating Agonist-Promoted G Protein-Coupled Receptor Internalization , 1996, Science.

[95]  A. Strosberg,et al.  Beta(2)-adrenergic receptor down-regulation. Evidence for a pathway that does not require endocytosis. , 1999, The Journal of biological chemistry.

[96]  S. Snyder,et al.  Differential effects of protein-modifying reagents on receptor binding of opiate agonists and antagonists. , 1975, Molecular pharmacology.

[97]  H. Loh,et al.  Ability of delta-opioid receptors to interact with multiple G-proteins is independent of receptor density. , 1994, The Journal of biological chemistry.

[98]  Christopher J. Evans,et al.  Morphine Activates Opioid Receptors without Causing Their Rapid Internalization* , 1996, The Journal of Biological Chemistry.

[99]  E. J. Simon,et al.  Kinetics of opiate receptor inactivation by sulfhydryl reagents: evidence for conformational change in presence of sodium ions. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[100]  N. E. Larsen,et al.  Protection of opiate receptors in NG108-15 against modification by N- ethylmaleimide , 1983, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[101]  S. Kato,et al.  Location of Regions of the Opioid Receptor Involved in Selective Agonist Binding (*) , 1995, The Journal of Biological Chemistry.

[102]  H. Loh,et al.  Visualization of time-dependent redistribution of delta-opioid receptors in neuronal cells during prolonged agonist exposure. , 1999, Brain research. Molecular brain research.

[103]  P. Seeburg,et al.  Molecular characterization of a new immunoglobulin superfamily protein with potential roles in opioid binding and cell contact. , 1989, The EMBO journal.

[104]  F. Medzihradsky,et al.  Receptor-mediated stimulation of brain GTPase by opiates in normal and dependent rats. , 1984, Biochemical and biophysical research communications.

[105]  K. Befort,et al.  The delta-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[106]  E. J. Simon,et al.  Tyrosine phosphorylation of the delta-opioid receptor. Evidence for its role in mitogen-activated protein kinase activation and receptor internalization*. , 2000, Biochemical pharmacology.

[107]  G. Bell,et al.  Cloning and functional comparison of kappa and delta opioid receptors from mouse brain. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[108]  T. Nakagawa,et al.  DAMGO, a μ‐opioid receptor selective ligand, distinguishes between μ‐and κ‐opioid receptors at a different region from that for the distinction between μ‐ and δ‐opioid receptors , 1995 .

[109]  K. Fukuda,et al.  Identification of the amino acid residues involved in selective agonist binding in the first extracellular loop of the δ‐ and μ‐opioid receptors , 1995 .

[110]  J. K. de Riel,et al.  Characterization of Irreversible Binding of -Funaltrexamine to the Cloned Rat Opioid Receptor (*) , 1995, The Journal of Biological Chemistry.

[111]  Howard Riezman,et al.  Ubiquitination of a Yeast Plasma Membrane Receptor Signals Its Ligand-Stimulated Endocytosis , 1996, Cell.

[112]  C. Chen,et al.  Differential binding domains of peptide and non-peptide ligands in the cloned rat kappa opioid receptor. , 1994, The Journal of biological chemistry.

[113]  M. Nishi,et al.  Primary structures and expression from cDNAs of rat opioid receptor δ‐and μ‐subtypes , 1993 .

[114]  A. Gingras,et al.  μ-Opioid Receptor Activates Signaling Pathways Implicated in Cell Survival and Translational Control* , 1998, The Journal of Biological Chemistry.